HCA Forensic analysis

Trading Setup & Entry Strategy

HCA is currently exhibiting an oversold condition (RSI 26.94) following a sharp 14.11% decline over the last 20 days. While the momentum is bearish (Death Cross imminent), the stock is testing significant support at the Bollinger Lower Band ($403.75). We are looking for a mean-reversion trade rather than a long-term bottoming play.

• >Entry Zone: $398.00 - $405.00. Accumulate 40% of position at current levels, 60% if the stock tests $398 (psychological support/recent swing low).
• >Stop Loss: $388.00 (Hard stop). A breach of this level invalidates the short-term recovery thesis.
• >Take Profit: $422.00 (5-day SMA) and $426.00 (10-day SMA).
• >Risk/Reward: ~1:2.3.
• >Max Hold: 5-7 days.

Executive Summary

HCA is facing temporary headwinds from the expiration of Enhanced Premium Tax Credits (EPTCs) and a lighter-than-expected seasonal respiratory volume. Despite this, the company maintains a robust balance sheet and is a master of cash flow deployment (aggressive share buybacks). The current sell-off appears overextended relative to fundamental reality, provided the regulatory outlook on Medicaid supplemental payments remains stable. Rating: BUY (Contrarian/Mean Reversion).

Recent Material Events (8-K Analysis)

Recent filings indicate no major negative surprises, but underscore ongoing commitment to capital allocation, including a quarterly dividend declaration of $0.78 per share (payable June 30, 2026).

Financial Health

• >Revenue Quality: Revenue grew 4.3% YoY to $19.11B. However, uninsured admissions spiked 15.6%, confirming the EPTC expiration impact.
• >Cash Flow: Operating cash flow remains strong at $2.01B for Q1 2026, despite a heavy $1.12B capex program.
• >Liquidity: Working capital is tight due to rising short-term commercial paper debt, but the $4.34B credit facility provides ample buffer.

Technical Analysis & Trade Timing

• >Trend: BEARISH_CROSSING. Price is significantly below the 50-SMA ($470.71) and 200-SMA ($461.83).
• >Indicator Signal: OVERSOLD. The RSI at 26.94 is a classic contrarian buy signal for high-quality names.
• >Reconciliation: While fundamentals remain sound, the technical trend is clearly in distribution. The trade must be treated as a swing trade, not a long-term anchor position until the 50-SMA is reclaimed.

Short-Term Trading Strategy (2-5 Days)

• >Timeframe: Swing Trade (2–5 Days)
• >Position Sizing: 3% of portfolio.
• >Scaling Strategy: Enter 30% at $404.69, add 40% at $398, add remaining 30% on a bounce confirming support.
• >Take Profit: 50% at $422.00, 50% at $430.00.

One-Liner Thesis: HCA is a fundamentally dominant operator caught in an overdone technical liquidation triggered by temporary policy headwinds; the current oversold status offers a high-probability mean-reversion setup.